Eslicarbazepine acetate
Aptiom, Zebinix (eslicarbazepine acetate) is a small molecule pharmaceutical. Eslicarbazepine acetate was first approved as Aptiom on 2009-04-21. It has been approved in Europe to treat epilepsy. Aptiom's patents are valid until 2032-08-24 (FDA).
| Trade Name | Zebinix |
|---|---|
| Common Name | Eslicarbazepine acetate |
| Indication | epilepsy |
| Drug Class | Tricyclic compounds |
